R76-43831-82427
4 vaccinations
2 coded responses
52 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 208 / MD
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
L8V-81788-27754
Child or adolescent in my care · Female · 2021-11-06
48E-30434-88257
Child or adolescent in my care · Male · 2022-06-23
Y5Y-41992-08837
Child or adolescent in my care · Male · 2022-08-24
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Pfizer-BioNTech
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
-
2021-03-10
Dose 2 — Pfizer-BioNTech
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-09
-
2021-09-08
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Heart valve incompetence — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Heart regurgitation - get out of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-09-08
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-10
- 2021-09-14
-
2021-09-14
Callback requested for08:00AM ET
-
2021-10-21
Dose 3 — Pfizer-BioNTech
- 2021-10-21
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-11-04
- 2021-11-13
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2022-01-20
- 2022-04-21
-
2022-10-18
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-18
- 2022-10-19
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2023-01-17
-
2023-04-18
Survey response — 6 months, dose 4MedDRA: Fatigue, Headache, Pain, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-10-18 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Heart regurgitation - get out of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart valve incompetence | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release